Hidradenitis Suppurativa (HS) is a non-contagious, chronic, and painful skin disease. It affects approximately 1% of the population. The onset of HS typically occurs after puberty and more commonly affects women. HS is characterized by recurring red swollen lumps and cysts with pus, which can rupture to form tracts and may cause scarring. It typically affects the armpits, groin and thigh areas, or under the breasts in women.
Hidradenitis Suppurativa is generally considered to be due to follicular occlusion. Factors such as genetics, smoking, and obesity appear to be predisposing factors to this disease.
There is no known cure for Hidradenitis Suppurativa and current treatments are dependent on the severity of the disease. Current treatment options include topical clindamycin, systemic antibiotics, intralesional steroids, excision of affected areas, oral retinoids, anti-androgens, immunosuppressents, and long-term systemic medical therapy.
All information about you will be kept confidential.
If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.
Regulatory agencies like Health Canada and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more